Skip to main content

Table 7 Absorption, distribution and metabolism of betulinic acid

From: Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2)

Absorption

HIA (%)

PCaco-2 (nm/s)

Pskin

96.00

21.86

−2.11

Distribution

PPB (%)

Cbrain/Cblood

P-Glycoprotein (Inhibition)

P-Glycoprotein (Substrate)

100.00

8.20

Inhibitor

Substrate

Metabolism

Phase I

Phase II

Enzyme

Inhibitor/Substrate

Enzyme

Substrate/Non-substrate

Cytochrome P450 2C19 (Inhibitor)

Non

UDP-glucuronosyltransferase (UGT)

Non-substrate

Cytochrome P450 2C9 (Inhibitor)

Inhibitor

Sulfotransferase (SULT)

Non-substrate

Cytochrome P450 2D6 (Inhibitor)

Non

  

Cytochrome P450 2D6 (substrate)

Non

  

Cytochrome P450 3A4 ((Inhibitor)

Inhibitor

  

Cytochrome P450 3A4 (substrate)

Substrate

 Â